Gastrointestinal comorbidities associated with atrial fibrillation.
This observational study was conducted to describe the risk of gastrointestinal (GI) events among patients with atrial fibrillation (AF). We analyzed Thomson Reuters MarketScan® data from 2005 to 2009. Subjects aged ≥18 years with ≥ 1 AF diagnosis were selected. GI events were identified from claims with a primary or secondary diagnosis code for any GI condition. The risk of GI events was assessed using cumulative incidence (new GI events/patients with AF without GI condition at baseline) and incidence rates (IRs), calculated as the number of patients with new GI events divided by patient-years of observation. In addition, the CHADS2 score was evaluated at baseline to determine the patient's risk of stroke. A total of 557,123 AF patients were identified. The mean (median) AF patient age was 68.2 years (70); 45% were female. The cumulative incidences of any GI event and dyspepsia were 40% and 19%, respectively. The corresponding IRs were 38.8 and 14.7 events per 100 patient-years. IRs of any GI events for female and male patients were 43.6 and 35.5; for patients in the age groups <65, 65-74, 75-84, and ≥85 years, IRs were 32.3, 38.9, 44.6, and 52.7; for patients with a CHADS2 score of 0, 1-2, 3-4, and 5-6, IRs were 30.3, 41.6, 56.9, and 74.5, respectively. In this large claims database, 40% of AF patients experienced a GI event, predominantly dyspepsia. Physicians should take age and comorbidities into consideration when managing AF patients.
Groupe d'analyse, Ltée, 1000 rue de la Gauchetière Ouest, Bureau 1200, Montréal, Québec H3B 4 W5 Canada.
François
F
Laliberté
Groupe d'analyse, Ltée, 1000 rue de la Gauchetière Ouest, Bureau 1200, Montréal, Québec H3B 4 W5 Canada.
Yuliya
Y
Moore
Groupe d'analyse, Ltée, 1000 rue de la Gauchetière Ouest, Bureau 1200, Montréal, Québec H3B 4 W5 Canada.
Katherine
K
Dea
Janssen Scientific Affairs, LLC, Raritan, NJ USA.
Joyce C
JC
LaMori
Janssen Scientific Affairs, LLC, Raritan, NJ USA.
Samir H
SH
Mody
Janssen Scientific Affairs, LLC, Raritan, NJ USA.
JaCinda L
JL
Jones
Janssen Scientific Affairs, LLC, Raritan, NJ USA.
Michele D
MD
Arledge
Janssen Scientific Affairs, LLC, Raritan, NJ USA.
C V
CV
Damaraju
Janssen Scientific Affairs, LLC, Raritan, NJ USA.
Jeff R
JR
Schein
Groupe d'analyse, Ltée, 1000 rue de la Gauchetière Ouest, Bureau 1200, Montréal, Québec H3B 4 W5 Canada.
Patrick
P
Lefebvre
Atrial fibrillation; Dyspepsia; Gastrointestinal conditions; Risk